Bringing down the high cost of prescription drugs was a staple of President Trump's presidential campaign. On the campaign trail, Trump proposed allowing Medicare to bargain with pharmaceutical firms to set prices, and letting consumers import less expensive drugs from Canada. However, neither of those ideas made it into the administration's plan to lower drug costs, which was released last month with great fanfare. What exactly is in the Trump administration's proposal, and how likely is it to succeed? In this MedPage Today video commentary, Carolyn Engelhard, MPA, director of health policy a...